Kewaunee Scientific CORP: insider trades · United States · SEC (Form 4)

About Kewaunee Scientific CORP

Kewaunee Scientific Corp /DE/ (NASDAQ: KEQU, United States) is a niche provider of laboratory, healthcare, and technical furniture and infrastructure solutions. Founded in 1906, the company has developed a long operating history in a specialized market where execution quality, compliance, and the ability to deliver complex projects matter as much as product design. Its corporate headquarters are in Statesville, North Carolina, and it maintains commercial operations in the United States, India, Saudi Arabia, and Singapore. Kewaunee also operates manufacturing facilities in Statesville and in Bengaluru, enabling it to serve domestic and international demand. ([kewaunee.com](https://kewaunee.com/wp-content/uploads/2025/07/FY25-Annual-Report-Proof-FINAL.pdf)) The company’s core business centers on laboratory fit-out and technical furnishings. Its product range includes steel and wood casework, fume hoods, adaptable modular systems, movable workstations, stand-alone benches, epoxy resin work surfaces and sinks, and related infrastructure for scientific environments. In November 2024, Kewaunee expanded its portfolio through the acquisition of NuAire, adding biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products. NuAire broadens the group’s offering and strengthens its ability to sell more comprehensive solutions to research, healthcare, and life-science customers. Kewaunee also provides facility design, detailed engineering, project management, and commissioning services, particularly in its international business. ([kewaunee.com](https://kewaunee.com/wp-content/uploads/2025/07/FY25-Annual-Report-Proof-FINAL.pdf)) From a competitive standpoint, Kewaunee operates in a highly fragmented but demanding industry tied to laboratory, hospital, university, pharmaceutical, and industrial capital spending. Its differentiators include manufacturing know-how, a dealer-based go-to-market model, international reach, and a broader product mix following the NuAire acquisition. Rather than competing only on furniture, the company increasingly presents itself as a solutions provider for fully equipped laboratory spaces, which can improve customer stickiness and project scope. ([kewaunee.com](https://kewaunee.com/wp-content/uploads/2025/07/FY25-Annual-Report-Proof-FINAL.pdf)) Recent developments are relevant for investors. Company disclosures for fiscal 2026 show solid operational momentum, including strong year-over-year sales growth in the second quarter and an increase in pre-tax earnings in the third quarter. Management has also pointed to a healthy backlog and the contribution from NuAire, while cautioning that quarterly results may remain uneven because of project timing and supply-chain disruption. For French-speaking investors, KEQU is best viewed as a specialized industrial healthcare/life-science supplier listed on the NASDAQ in the United States, with a history, international footprint, and product breadth that support its niche market position. ([sec.gov](https://www.sec.gov/Archives/edgar/data/55529/000005552925000051/prfy26q2earningsrelease.htm?utm_source=openai))